Emerging evidence on the role of soy in reducing prostate cancer risk

Research output: Contribution to journalReview articlepeer-review

Abstract

Soyfoods are a unique dietary source of isoflavones, which have both hormonal and non-hormonal effects relevant to prostate cancer prevention. In vitro, the main soybean isoflavone, genistein, inhibits prostate cancer cell growth; in animals, most but not all studies show isoflavone-rich soy protein and isolated isoflavones inhibit prostate tumor development. Currently, although only limited epidemiologic data indicate soy intake reduces prostate cancer risk, results from a pilot intervention trial suggest isoflavones may be beneficial to prostate cancer patients. For several reasons, men concerned about their prostate health may consider incorporating soy into their diet.

Original languageEnglish
Pages (from-to)117-131
Number of pages15
JournalNutrition Reviews
Volume61
Issue number4
DOIs
StatePublished - Apr 1 2003

ASJC Scopus Subject Areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Keywords

  • Cancer
  • Genistein
  • Isoflavones
  • Prostate
  • Review
  • Soy

Cite this